Disuse Atrophy
9
0
0
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (9)
Prehabilitative Exercise Prior to Immobilization
Molecular Mechanisms Underlying Anabolic Resistance to Protein Intake During Muscle Disuse
The Efficacy of Protein Supplementation on Attenuating Muscle Atrophy Following Disuse in the Collegiate Population
Preventing Bed-rest Induced Muscle Loss in the Elderly
Bed-rest, Muscle Mass and Insulin Sensitivity
Effects of Kneehab 12-week Peri-operative Total Knee Arthroplasty
Immobilization and Protein Supplementation (IM-PRO)
Electrical Stimulation During Immobilization
Leucine Supplementation and Skeletal Muscle Disuse